Cable and broadband providers have received regulatory clearance from California after agreeing to some concessions on affordability. Applied Materials Stock Falls After Earnings Weren't Quite Good ...

U.S. stocks rose and the S&P 500 closed at a record high after a report of moderated wholesale inflation eased interest-rate fears. U.S. Producer-Price Index Unchanged in July The producer-price index ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Cleveland Fed President Beth Hammack has called out the high level and persistence of inflation. Bill Ackman Calls His New Fund's Slumping Stock Price 'Frankly Absurd' The billionaire investor's ...

Car loans are hitting a new gear in pressuring drivers' wallets. Americans took out almost $211 billion in auto loans this past spring, notching a new record, according to the Federal Reserve Bank of ...

I would appreciate some input on whether it makes sense to pay off our mortgage. My wife and I are both retired. We have approximately $2.3 million in savings and investments, with about 90% invested ...

Shares of Dell have roughly quadrupled in price this year, with Lenovo's earnings report helping to drive the latest bout of momentum for the PC and server maker Dell's stock has essentially ...

An analyst predicts 29% upside for Salesforce shares, citing some promising AI features J.P. Morgan analyst Samik Chatterjee now has an overweight rating on Salesforce shares. Investors have been ...

(New Issue) The 10-year yield declined 0.051 percentage point to 4.640% today. The price is 99 28/32. --Largest one-day yield decline since Tuesday, Aug. 4, 2026 --Yield is down for three consecutive ...

Shares of the HR software company rose 18% on Thursday on reports of a potential private-equity acquisition With Workday holding a market capitalization near $51 billion, a takeover by Silver Lake ...

Despite low volatility, investors suddenly accelerated their buying of disaster insurance to protect against a surprise crash Markets look deceptively calm. After a brief pause in June and July, U.S.

Bristol Myers Squibb received approval for Zenbexus to be used as a treatment for multiple myeloma when combined with certain other drugs. The biopharmaceutical manufacturer said Thursday the Food and ...